Heparin-induced vascular occlusion in vasculosurgical patients. An evaluation of the disease in 13 cases

Journal of Cardiovascular Surgery

Volumn 40, Issue 2, 1999, Pages 237-242

  Buerger, Th ^a   Tautenhahn, J ^b   Meyer, F ^b   Lippert, H ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b NONE

Author keywords

Anticoagulants, adverse effects; Heparin adverse effects; Thrombocytopenia, chemically induced; Thromboembolism complications; Whit clot syndrome

Indexed keywords

ACETYLSALICYLIC ACID; DANAPAROID; DEXTRAN; HEPARIN; HEPARINOID; HIRUDIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; AMPUTATION; ARTICLE; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CROSS REACTION; EMBOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISCHEMIA; LABORATORY TEST; PROPHYLAXIS; THROMBOCYTE COUNT; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPENIA; THROMBOSIS; VASCULAR SURGERY;

ADULT; ANTICOAGULANTS; FEMALE; HEPARIN; HUMANS; MIDDLE AGED; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; THROMBOCYTOPENIA; VASCULAR DISEASES;

EID: 0032939445     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bergquist D, Flordal PA, Friherg B, Frisell J, Hedberg M, Ljungström KG et al. Thromboprophylaxis with a low molecular weight heparin (Tinzaparin) in emergency abdominal surgery. VASA 1996;25: 156-60.
2. Baritt DW, Jordon SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1960;1:1309-12.
3. Encke A. Thromboembolieprophylaxe in der Allgemeinchirurgie. Chirurg 1992;63:264-70.
4. King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 1984;100:525-40.
5. Weismann RE, Tobin RW. Arterial embolism occurring during systematic heparin therapy. Arch Surg 1958;76:219-21.
6. Blank M, Cines DB, Arepaly G, Eldor A, Afek A, Shoenfeld Y. Pathogenity of human anti-platelet factor (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin. Clin Exp Immunol 1997;108:333-9.
7. Killer S, Zoppi M, Künzi UP, Hess T, Galeazzi RL, Muller U et al. Heparin-induced thrombocytopenia: results from the comprehensive hospital drug monitoring (CHDM). Bern/St. Gallen (German): Schweiz Med Wochenschr 1995;125:2518-22.
8. Powers PJ, Kelton JG, Carter CJ. Studies on the frequency of heparin-associated thrombocytopenia. Thromb Res 1984;33:439-43.
9. Warkentin TE, Leveine MN, Hirsh J, Horsewood P, Roberts RS, Gent M et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.
10. Malcolm ID, Wigmore TA, Steinbrecher UP. Heparin-associated thrombocytopenia: low frequency in 104 patients treated with heparin of intestinal mucosal origin. Can Med Assoc J 1979; 120:1086-8.
11. Kappers-Klunne MC, Boon DMS, Hop WCJ, Michiels JJ, Stibbe J, van der Zwaan C et al. Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases. Br J Haematol 1997;96:442-6.
12. Amiral J, Bridey F, Dreyfus M, Vissoc AM, Fressinaud E, Wolf M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992;68:95-6.
13. Makhoul RG, Greenberg CS, McCann RL. Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution. J Vasc Surg 1986;4:523-8.
14. Stanton PE, Evans JR, Lefemine AA, Vo NM, Rannick GA, Morgan CV et al. White clot syndrome. South Med J 1988;81:616-20.
15. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996;101:502-7.
16. Greinacher A. Heparin-assoziierte Thrombozytopenien. Diagnose & Labor 1993;43:124-9.
17. Scharf RE, Greinacher A, Riess H, Breddin HK, Leserbrief. Dtsch Arztebl 1994;24:1293-4.
18. Magnani HN. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 1993;70:554-61.
19. Chong BH. Heparin-induced thrombocytopenia Aust NZ J Med 1992;22:145-52.
20. Vun CM, Evans S, Chong BH. Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopenia. Thromb Res 1996;81:525-32.
21. Laster J, Cikrit D, Wlaker N, Silver D. The heparin-induced thrombocytopenia syndrome: an update. Surgery 1987;102:762-8.
22. Siver D, Kapsch DN, Tsoi EKM. Heparin-induced thrombocytopenia, thrombosis, and hemorrhage. Ann Surg 1983;198:301-5.
23. Lewis BE, Walenga JM, Wallis DE. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and thrombosis. Semin Thromb Haemost 1997;23:197-202.